no small cell lung caner 非小细胞性肺癌
Objective: To explore the clinical value of the detection of the serum sulfate glycosaminoglycan in the diagnosis of no small cell lung caner (NSCLC).
目的:探讨血清硫酸粘多糖片段的检测对非小细胞性肺癌诊断的临床应用价值,为肺癌的早期诊断提供依据。
No benefit was seen among patients with predominantly squamous cell cancer. The drug is not approved for patients with squamous cell non-small cell lung cancer.
大部分鳞状细胞癌患者当中没有明确有获益。该药不被批准用于鳞状非小细胞肺癌患者维持治疗。
Results the patient was 30 years old, male, having his clinical manifestations. Compared with small cell lung cancer (SCLC), there was no particularity.
结果患者为30岁男性,临床表现与肺小细胞癌相比无特殊性。
应用推荐